Zurich Cantonal Bank’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.8M | Sell |
35,685
-1,462
| -4% | -$820K | 0.04% | 363 |
|
|
2026
Q1 | $20.9M | Buy |
37,147
+2,991
| +9% | +$1.92M | 0.05% | 328 |
|
|
2025
Q4 | $23.1M | Buy |
34,156
+11,738
| +52% | +$7.99M | 0.05% | 298 |
|
|
2025
Q3 | $14.3M | Buy |
22,418
+780
| +4% | +$473K | 0.03% | 392 |
|
|
2025
Q2 | $11.6M | Sell |
21,638
-10,537
| -33% | -$5.04M | 0.03% | 428 |
|
|
2025
Q1 | $13.5M | Buy |
32,175
+309
| +1% | +$134K | 0.04% | 390 |
|
|
2024
Q4 | $13.2M | Sell |
31,866
-3,810
| -11% | -$1.67M | 0.04% | 375 |
|
|
2024
Q3 | $18M | Buy |
35,676
+2,258
| +7% | +$1.1M | 0.05% | 311 |
|
|
2024
Q2 | $16.3M | Buy |
33,418
+7,039
| +27% | +$3.53M | 0.05% | 302 |
|
|
2024
Q1 | $14.2M | Sell |
26,379
-129
| -0.5% | -$70.5K | 0.05% | 324 |
|
|
2023
Q4 | $14.7M | Buy |
26,508
+1,491
| +6% | +$700K | 0.06% | 301 |
|
|
2023
Q3 | $10.9M | Sell |
25,017
-6,944
| -22% | -$3.46M | 0.05% | 328 |
|
|
2023
Q2 | $16.1M | Buy |
31,961
+8,093
| +34% | +$3.88M | 0.07% | 244 |
|
|
2023
Q1 | $11.9M | Buy |
23,868
+2,118
| +10% | +$1.01M | 0.06% | 303 |
|
|
2022
Q4 | $8.87M | Sell |
21,750
-310
| -1% | -$120K | 0.05% | 354 |
|
|
2022
Q3 | $7.19M | Buy |
22,060
+2,077
| +10% | +$763K | 0.04% | 380 |
|
|
2022
Q2 | $7.01M | Sell |
19,983
-768
| -4% | -$313K | 0.04% | 383 |
|
|
2022
Q1 | $11.4M | Sell |
20,751
-3,893
| -16% | -$2.05M | 0.06% | 321 |
|
|
2021
Q4 | $16.2M | Sell |
24,644
-3,317
| -12% | -$2.08M | 0.08% | 238 |
|
|
2021
Q3 | $17.4M | Sell |
27,961
-3,620
| -11% | -$2.43M | 0.09% | 203 |
|
|
2021
Q2 | $19.9M | Buy |
31,581
+5,994
| +23% | +$3.31M | 0.11% | 179 |
|
|
2021
Q1 | $12.5M | Buy |
25,587
+791
| +3% | +$396K | 0.07% | 253 |
|
|
2020
Q4 | $12.4M | Sell |
24,796
-1,650
| -6% | -$738K | 0.08% | 249 |
|
|
2020
Q3 | $10.4M | Buy |
26,446
+7,014
| +36% | +$2.59M | 0.07% | 248 |
|
|
2020
Q2 | $6.42M | Sell |
19,432
-2,696
| -12% | -$781K | 0.06% | 325 |
|
|
2020
Q1 | $5.36M | Buy |
22,128
+1,800
| +9% | +$470K | 0.05% | 350 |
|
|
2019
Q4 | $5.31M | Buy |
20,328
+126
| +0.6% | +$33.2K | 0.04% | 419 |
|
|
2019
Q3 | $5.49M | Buy |
20,202
+781
| +4% | +$217K | 0.05% | 393 |
|
|
2019
Q2 | $5.35M | Sell |
19,421
-525
| -3% | -$129K | 0.05% | 408 |
|
|
2019
Q1 | $4.46M | Buy |
19,946
+151
| +0.8% | +$31.2K | 0.04% | 431 |
|
|
2018
Q4 | $3.68M | Sell |
19,795
-2,887
| -13% | -$592K | 0.04% | 450 |
|
|
2018
Q3 | $5.66M | Buy |
22,682
+522
| +2% | +$127K | 0.05% | 394 |
|
|
2018
Q2 | $4.83M | Buy |
22,160
+284
| +1% | +$58.5K | 0.04% | 431 |
|
|
2018
Q1 | $4.19M | Hold |
21,876
| – | – | 0.04% | 454 |
|
|
2017
Q4 | $3.42M | Buy |
21,876
+1,787
| +9% | +$281K | 0.03% | 501 |
|
|
2017
Q3 | $3.12M | Hold |
20,089
| – | – | 0.03% | 509 |
|
|
2017
Q2 | $3.24M | Sell |
20,089
-1,560
| -7% | -$253K | 0.03% | 503 |
|
|
2017
Q1 | $3.35M | Hold |
21,649
| – | – | 0.03% | 505 |
|
|
2016
Q4 | $2.54M | Buy |
21,649
+488
| +2% | +$55.7K | 0.03% | 565 |
|
|
2016
Q3 | $2.38M | Buy |
21,161
+11,031
| +109% | +$1.16M | 0.02% | 576 |
|
|
2016
Q2 | $941K | Buy |
10,130
+7,731
| +322% | +$664K | 0.01% | 704 |
|
|
2016
Q1 | $188K | Hold |
2,399
| – | – | ﹤0.01% | 933 |
|
|
2015
Q4 | $175K | Buy |
2,399
+1,272
| +113% | +$90.7K | ﹤0.01% | 951 |
|
|
2015
Q3 | $84K | Buy |
1,127
+815
| +261% | +$58.4K | ﹤0.01% | 992 |
|
|
2015
Q2 | $20K | Sell |
312
-15,590
| -98% | -$1.08M | ﹤0.01% | 1101 |
|
|
2015
Q1 | $1.23M | Buy |
+15,902
| New | +$1.24M | 0.02% | 651 |
|
Other funds holding IDXX
Zurich Cantonal Bank's IDXX Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Idexx Laboratories (IDXX) stake by 3.9% in Q2 2026, selling an estimated $820K and leaving 35,685 shares worth $18.8M. The position accounts for 0.04% of the portfolio, ranked #363.
Zurich Cantonal Bank first reported a position in IDXX in Q1 2015 and has held it in 46 quarters since. The position peaked at $23.1M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Zurich Cantonal Bank held 35,685 shares of Idexx Laboratories worth $18.8M as of Q2 2026.
- Zurich Cantonal Bank sold 1,462 Idexx Laboratories shares in Q2 2026, an estimated $820K.
- Idexx Laboratories made up 0.04% of Zurich Cantonal Bank's portfolio in Q2 2026, its #363 holding.
- Zurich Cantonal Bank first reported a position in Idexx Laboratories in Q1 2015 and has held it in 46 quarters since.
- Zurich Cantonal Bank's Idexx Laboratories position peaked at $23.1M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.